精品国产一区二区桃色

Journal News

A mold鈥檚 dangerous responses to its environment

Laurel Oldach
Jan. 19, 2021

Aflatoxins are among the most dangerous of natural products. At a high dose, the toxins can cause fatal liver failure; at lower doses, by forming adducts with guanine bases in DNA, they can cause mutations that lead to liver cancer.

Mold-445x334.jpg
Janice Haney Carr and Robert Simmons
A scanning electron micrograph shows the fruiting body of an Aspergillus fungus.

The toxins are made by filamentous fungi in the Aspergillus family found in soil and are able to colonize the grains and seeds that constitute many of the world's most important food crops. Aspergilli don't need aflatoxins to survive; they activate aflatoxin synthesis in response to environmental conditions, especially heat and moisture. Since hotter days are coming worldwide, researchers would like to find strategies to reduce aflatoxin production.

The genome of Aspergillus flavus, the chief culprit in introducing aflatoxin to human and animal food supplies, first was sequenced in 2006. But there's a difference between knowing what sequences are in a genome and knowing what they do; many sections of the A. flavus genome have not been annotated, meaning that researchers have had little insight into their function.

In in the journal Molecular & Cellular Proteomics, researchers at the Fujian Agriculture and Forestry University in China, led by Mingkun Yang, report on a proteogenomic analysis of A. flavus. By using the whole fungal genome instead of only its known coding sequences as the reference database to identify peptides detected through mass spectrometry, the team discovered over 700 new protein-coding genes.

"The authors provide a significant improvement to the genome annotation in Aspergillus and demonstrate the use of proteogenomics as a tool especially in organisms lacking high-quality genome annotations," one anonymous peer reviewer wrote.

Researchers cultured the fungus under cold, salty and oxidative stress conditions to maximize phenotypic variability, and they were rewarded: The fungi expressed a smorgasbord of proteoforms, including over 200 new-to-science splice variants, some single-amino-acid variants and a few unexpected intergenic peptides. In follow-up quantitative PCR experiments, the researchers observed that stressful conditions substantially affected the expression of some of the new genes.

Based on homology to other, better-annotated proteins in the literature, the authors think that they may have identified new metabolic enzymes, signaling proteins and stress response factors. They have not yet determined whether any of the new genes are involved in aflatoxin production.

According to the researchers, follow-up studies of the new protein-coding genes and when and where they are expressed may improve our understanding of when and why aflatoxin is produced.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.